|
(P753) |
Increased myocardial sodium storage in Conn’s syndrome detected by 23Na magnetic resonance imaging. |
| |
|
M. Christa, A. Weng, F. Hammer, B. Geier, C. Wörmann, B. J. Kraus, S. Hahner, S. Störk, W. R. Bauer, T. Klink, H. Köstler (Würzburg, Greifswald) |
|
(P754) |
Long-term results obtained by CMR and alternative imaging techniques in cardiac sarcoidosis |
| |
|
C. Pizarro, F. Klünker, R. Schueler, D. Thomas, F. Gärtner, C. Grohé, G. Nickenig, D. Skowasch (Bonn, Berlin) |
|
(P755) |
Identification of cardiomyopathy-associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiac imaging and plasma profiling approach |
| |
|
A. R. Florian, S. Becker, I. A. Patrascu, S. Rösch, J. Waltenberger, U. Sechtem, M. Schwab, E. Schäffeler, A. Yilmaz (Münster, Stuttgart) |
|
(P756) |
Myocardial characteristics of patients with Addison disease and long term Cortisol replacement therapy in cardiac MRI |
| |
|
T. Reiter, C. Schirpenbach, T. Kampf, N. Rugenstein, A. L. Martinez, C. Kwasny, I. Perdijk, S. Hahner, W. R. Bauer (Würzburg) |
|
(P757) |
Echocardiographic follow-up of patients with malignant melanoma under therapy with Dabrafenib: A speckle tracking study. |
| |
|
D. Schiller, F. Knebel, H. Dreger, B. Hewing, G. Baumann, U. Trefzer, S. Spethmann (Berlin) |
|
(P758) |
What does MRI imaging add to the ESC risk prediction model to assess the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy ? |
| |
|
C. Dösch, S. Oezkan, I. Akin, E. Tueluemen, B. Rudic, D. Loßnitzer, M. Behnes, S. O. Schönberg, M. Borggrefe, T. Papavassiliu (Mannheim) |